Unique channeling device used to relieve severe chest pain and treat heart disease tested at Rush-Presbyterian-St. Luke's Medical center

January 18, 2000

Today, Fred May, a 67-year old Evansville, Ind. man, is among the first patients in the United States to receive a unique, non-surgical treatment for severe coronary artery heart disease at Rush-Presbyterian-St. Luke's Medical Center in Chicago.

The catheterization procedure, called percutaneous myocardial channeling (PMC) seeks to stimulate blood flow in the heart to relieve pain from angina by creating channels in the inner wall of the heart. These channels, it is thought, promote the growth of new blood vessels (a process known as angiogenesis) to improve blood supply to heart tissues in need of nourishment. Dr. Gary L. Schaer, director of the cardiac catheterization laboratory at the Rush Heart Institute and interventional cardiologist Dr. Jeffrey Snell, will perform the procedure as part of a Phase I clinical trial to determine the safety of this new procedure. Rush is one of only five medical centers in the U.S. and the only Chicago area medical center participating in the trial. May is the fourth patient treated in the clinical trial at Rush. As part of this Phase I study, Rush will treat six patients.

Myocardial channeling, developed by AngioTrax of Sunnyvale, Calif., involves threading a catheter with a rotating surgical blade attached at the end through the patient's femoral artery. While guided by an angiographic mapping technique, the cardiologist uses the device to create 15 to 20 channels in the heart muscle. The entire procedure takes approximately 90 minutes, can be done under local anesthesia, and does not involve surgery. Most patients will go home the next day and some may eventually be discharged the day of the procedure, according to Schaer. This contrasts with a four to five day hospital stay for surgery.

Rush has developed special expertise in treating end-stage coronary artery disease. In 1995, Rush was one of the only Chicago-based medical centers to participate in a clinical trial on transmyocardial revascularization. In 1999, Rush was among the handful of elite medical centers to begin using gene therapy injections for heart disease.

"If successful, myocardial channeling will add to our repertoire of therapies we can offer patients who are suffering from severe chest pain," said Dr. Schaer. An added benefit of AngioTrax device is that the cardiologist can preserve samples of the heart tissue for further study. Each year, approximately 80,000 Americans develop severe coronary artery disease that cannot be treated by conventional techniques, including bypass surgery or angioplasty. More than 7 million suffer from chest pain due to coronary artery disease.
Rush-Presbyterian-St. Luke's Medical Center includes the 809-bed Presbyterian-St. Luke's Hospital; 154-bed Johnston R. Bowman Health Center for the Elderly; Rush University (Rush Medical College, College of Nursing, College of Health Sciences and Graduate College); and seven Rush Institutes providing diagnosis, treatment and research into leading health problems. The medical center is the tertiary hub of the Rush System for Health, a comprehensive healthcare system capable of serving about three million people through its outpatient facilities and eight member hospitals.

Rush University Medical Center

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.